| Literature DB >> 32484965 |
Xu Feng1, Anthony Tubbs2, Chunchao Zhang1, Mengfan Tang1, Sriram Sridharan2, Chao Wang1, Dadi Jiang3, Dan Su1, Huimin Zhang1, Zhen Chen1, Litong Nie1, Yun Xiong1, Min Huang1, André Nussenzweig2, Junjie Chen1.
Abstract
Mechanistic understanding of how ionizing radiation induces type I interferon signaling and how to amplify this signaling module should help to maximize the efficacy of radiotherapy. In the current study, we report that inhibitors of the DNA damage response kinase ATR can significantly potentiate ionizing radiation-induced innate immune responses. Using a series of mammalian knockout cell lines, we demonstrate that, surprisingly, both the cGAS/STING-dependent DNA-sensing pathway and the MAVS-dependent RNA-sensing pathway are responsible for type I interferon signaling induced by ionizing radiation in the presence or absence of ATR inhibitors. The relative contributions of these two pathways in type I interferon signaling depend on cell type and/or genetic background. We propose that DNA damage-elicited double-strand DNA breaks releases DNA fragments, which may either activate the cGAS/STING-dependent pathway or-especially in the case of AT-rich DNA sequences-be transcribed and initiate MAVS-dependent RNA sensing and signaling. Together, our results suggest the involvement of two distinct pathways in type I interferon signaling upon DNA damage. Moreover, radiation plus ATR inhibition may be a promising new combination therapy against cancer.Entities:
Keywords: ATR; MAVS; cGAS/STING; radiation; type I interferon
Mesh:
Substances:
Year: 2020 PMID: 32484965 PMCID: PMC7361286 DOI: 10.15252/embj.2019104036
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598